RXi Pharmaceuticals (RXII) Reports Financial Results for the Third Quarter of 2009
11/16/2009 9:52:30 AM
More...
|
RXi Pharmaceuticals (RXII) Appoints Noah D. Beerman as CEO
11/6/2009 6:39:10 AM
More...
|
RXi Pharmaceuticals (RXII) to Present Data Demonstrating the Robust Performance of its RNAi Therapeutics Platform at Upcoming Scientific Conference
11/4/2009 9:39:18 AM
More...
|
RXi Pharmaceuticals (RXII) Presented New Pre-Clinical Animal Data at its Annual Investor Day
10/8/2009 9:09:26 AM
More...
|
RXi Pharmaceuticals (RXII) President and Chief Executive Officer to Ring The NASDAQ Stock Market Closing Bell
10/5/2009 10:35:13 AM
More...
|
RXi Pharmaceuticals (RXII) to Ring NASDAQ Stock Market Closing Bell
10/5/2009 9:59:40 AM
More...
|
First Set in a Series of siRNA Sequence Patent Applications Licensed to RXi Pharmaceuticals (RXII) are Allowed in the United States
10/1/2009 9:22:53 AM
More...
|
RXi Pharmaceuticals (RXII) to Webcast Investor Event on October 5, 2009
9/28/2009 9:42:03 AM
More...
|
RXi Pharmaceuticals (RXII) Obtains Direct Ownership of Previously Licensed RNAi Delivery Intellectual Property From Advirna LLC
9/25/2009 8:43:30 AM
More...
|
RXi Pharmaceuticals Announces Departure of CFO
8/21/2009 6:45:20 AM
More...
|
|